ELEVANCE HEALTH logo

ELEVANCE HEALTH (4ANTM)

Market Closed
19 Jun, 15:30
XMIL XMIL
321. 00
-5.5
-1.68%
- Market Cap
18.21 P/E Ratio
6.52% Div Yield
3 Volume
33.06 Eps
326.5
Previous Close
Day Range
321 331.7
Year Range
321 513.2
Want to track 4ANTM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 19 days

Summary

4ANTM closed Thursday lower at €321, a decrease of 1.68% from Wednesday's close, completing a monthly decrease of -6.69% or €23. Over the past 12 months, 4ANTM stock lost -10.51%.
4ANTM pays dividends to its shareholders, with the most recent payment made on Yesterday at 12:00 AM. The next estimated payment will be in In 2 months on Sep 25, 2025 for a total of €1.71.
The last earnings report, released on Apr 16, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.42%, based on the last three reports. The next scheduled earnings report is due on Jul 15, 2025.
ELEVANCE HEALTH has completed 1 stock splits, with the recent split occurring on Jun 01, 2005.
The company's stock is traded on 13 different exchanges and in various currencies, with the primary listing on NYSE (USD).

4ANTM Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
DEADLINE APPROACHING: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Inquire About a Securities Fraud Class Action by July 11, 2025

DEADLINE APPROACHING: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Inquire About a Securities Fraud Class Action by July 11, 2025

PHILADELPHIA , June 25, 2025 /PRNewswire/ -- Berger Montague PC  advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV) on behalf of purchasers of Elevance securities between April 18, 2024 through October 16, 2024, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired Elevance  securities during the Class Period may, no later than JULY 11, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Prnewswire | 1 hour ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV

ROSEN, LEADING INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

Globenewswire | 5 hours ago
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , June 25, 2025 /PRNewswire/ -- The Law Offices of Howard G.

Prnewswire | 11 hours ago

ELEVANCE HEALTH Dividends

Elevance Health Inc. logo
ELV In 2 months
Estimated
Quarterly
$1.71 Per Share
Elevance Health Inc. logo
ELV 2 weeks ago
Paid
Quarterly
$1.71 Per Share
Elevance Health Inc. logo
ELV 3 months ago
Paid
Quarterly
$1.71 Per Share
Elevance Health Inc. logo
ELV 6 months ago
Paid
Quarterly
$1.63 Per Share
Elevance Health Inc. logo
ELV 9 months ago
Paid
Quarterly
$1.63 Per Share
Elevance Health Inc. logo
ELV 10 Jun 2024
Paid
Quarterly
$1.63 Per Share

ELEVANCE HEALTH Earnings

15 Jul 2025 (In 2 weeks) Date
-
Cons. EPS
-
EPS
16 Apr 2025 Date
-
Cons. EPS
-
EPS
22 Jan 2025 Date
3.8
Cons. EPS
3.84
EPS
17 Oct 2024 Date
9.66
Cons. EPS
8.37
EPS
16 Oct 2024 Date
9.69
Cons. EPS
-
EPS
Elevance Health Inc. logo
ELV In 2 months
Estimated
Quarterly
$1.71 Per Share
Elevance Health Inc. logo
ELV 2 weeks ago
Paid
Quarterly
$1.71 Per Share
Elevance Health Inc. logo
ELV 3 months ago
Paid
Quarterly
$1.71 Per Share
Elevance Health Inc. logo
ELV 6 months ago
Paid
Quarterly
$1.63 Per Share
Elevance Health Inc. logo
ELV 9 months ago
Paid
Quarterly
$1.63 Per Share
Elevance Health Inc. logo
ELV 10 Jun 2024
Paid
Quarterly
$1.63 Per Share
15 Jul 2025 (In 2 weeks) Date
-
Cons. EPS
-
EPS
16 Apr 2025 Date
-
Cons. EPS
-
EPS
22 Jan 2025 Date
3.8
Cons. EPS
3.84
EPS
17 Oct 2024 Date
9.66
Cons. EPS
8.37
EPS
16 Oct 2024 Date
9.69
Cons. EPS
-
EPS

ELEVANCE HEALTH (4ANTM) FAQ

What is the stock price today?

The current price is €321.00.

On which exchange is it traded?

ELEVANCE HEALTH is listed on NYSE.

What is its stock symbol?

The ticker symbol is 4ANTM.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 6.52%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Jul 15, 2025.

Has ELEVANCE HEALTH ever had a stock split?

ELEVANCE HEALTH had 1 splits and the recent split was on Jun 01, 2005.

ELEVANCE HEALTH Profile

Medical - Healthcare Plans Industry
Healthcare Sector
Ms. Gail Koziara Boudreaux CEO
XMIL Exchange
US0367521038 ISIN
US Country
104,200 Employees
10 Mar 2025 Last Dividend
1 Jun 2005 Last Split
2 Jan 2001 IPO Date

Overview

Elevance Health, Inc., operating in the United States, is a comprehensive health benefits organization that was established in 2001. Initially known as Anthem, Inc., the company underwent a name change to Elevance Health, Inc. in June 2022, marking a new era in its operation. Headquartered in Indianapolis, Indiana, Elevance Health extends its services through a range of health plans and insurance products. The company's operations are segmented into four main divisions: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other, reflecting its vast spectrum of offerings in the health sector. Elevance Health is a key player in the health benefits space, leveraging its extensive network and services to cater to the diverse needs of its program members.

Products and Services

  • Health Plans and Services
  • Elevance Health provides a variety of health plans, including managed care services on a fee basis, catering to the needs of its members. This segment ensures access to quality healthcare and supports the wellbeing of individuals under its care.

  • Specialty and Insurance Products
  • Offering more than traditional health insurance, the company extends its portfolio to include stop loss, dental, vision, life, disability, and supplemental health insurance benefits. These products are designed to offer comprehensive coverage and peace of mind to members.

  • Pharmacy Services
  • Under its CarelonRx segment, Elevance Health operates in the pharmacy services business, providing crucial services like pharmacy benefit management, home delivery and specialty pharmacies, formulary management, pharmacy networks, and rebate administration. This comprehensive approach ensures accessibility and affordability of prescription medications.

  • Healthcare-related Services and Capabilities
  • The company also excels in delivering a wide range of healthcare-related services, including but not limited to utilization management, behavioral health, integrated care delivery, and palliative care. Additionally, it offers payment integrity services, subrogation services, and health and wellness programs, emphasizing its commitment to overall health management and cost containment.

  • National Government Services
  • Through its involvement in the National Government Services business, Elevance Health plays a crucial role in servicing government health programs. This segment underscores the company's expertise and capacity to handle large-scale, government-sponsored health initiatives efficiently.

  • Brands
  • Elevance Health serves its clients under well-established brand names such as Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon, aligning its diverse service offerings with trusted and recognized brands in the health industry.

Contact Information

Address: 220 Virginia Avenue
Phone: 800 331 1476